References
- Roberts A. J., Crabbe J. C., Keith L. D. Type I cortico‐ steroids receptors modulate PTZ‐induced convulsions of withdrawal seizure prone mice. Brain Res 1993; 626: 143–148
- Report from Boston Collaborative Drug Surveillance Program. Drug‐induced convulsions. Lancet 1972; 2: 677–679
- Bettinelli A., Paterlini G., Mazzucchi E., Giani M. Seizures and transient blindness following intravenous pulse methyl‐prednisolone in children with primary glomerulonephritis. Child Nephrol Urol 1991; 11: 41–43
- El‐Dahr S., Chevalier R. L., Gomez R. A., Campell F. G. Seizures and blindness following intravenous pulse methylprednisolone in a renal transplant patient. Int J Pediatr Nephrol 1987; 8: 87–90
- Yu E. C., Wong S. N., Yeung C. Y. Encephalopathy associated with steroid treated nephrotic syndrome. Int Pediatr Nephrol 1987; 8: 135–146
- Durrant S., Chipping P. M., Palmer S. Cyclosporin A, methyl‐prednisolone and convulsions. Lancet 1982; 27: 829
- Boogaerts M. A., Zachee P., Verurlghen R. L. Cyclo‐ sporine, methyl‐prednisolone and convulsions. Lancet 1982; 27: 1216
- Yang J. Y., Cui X. L., He X. J. Non‐ketotic hyperosmolar coma complicating steroid treatment in childhood nephrosis. Pediatr Nephrol 1995; 9: 621–622
- Ildirim I., Furcolow M. L., Vandiviere H. M. A possible explanation of post‐treatment convulsions associated with intrathecal corticosteroids. Neurology 1970; 20: 622–625
- Roberts A. J., Keith L. D. Mineralocorticoid receptors mediate the enhancing effects of corticosterone on convulsion susceptibility in mice. J Pharmacol Exp Ther 1994; 270: 505–511
- Reddy D. S., Kulkarni S. K. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydro‐ epiandrosterone sulfate in mice. Eur J Pharmacol 1998; 345: 55–59
- Kokate T. G., Juhng K. N., Kirkby R. D., Llamas J., Yamaguchi S., Rogawski M. A. Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Res 1999; 831: 119–124
- Rolla G., Bucca C., Bugiani M., Oliva A., Branciforte L. Hypomagnesemia in chronic obstructive lung disease: effect of therapy. Magnes Trace Elem 1990; 9: 132–136
- Galland L. Magnesium, stress, and neuropsychiatric disorders. Magnes Trace Elem 1991; 10: 287–301
- Ghezzi A., Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci 2001; 22: S117–S122
- Lossos A., River Y., Eliakim A., Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995; 45: 416–421
- Gendelman S., Present D., Janowitz H. D. Neurological complications of inflammatory bowel disease (IBD) [Abstract]. Gastroenterology 1982; 82: 1065
- Elsebety A. E., Bertorini T. E. Neurological complications in Crohn's disease [Abstract]. Ann Neurol 1991; 30: 271